1. Home
  2. BYD vs GKOS Comparison

BYD vs GKOS Comparison

Compare BYD & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYD
  • GKOS
  • Stock Information
  • Founded
  • BYD 1973
  • GKOS 1998
  • Country
  • BYD United States
  • GKOS United States
  • Employees
  • BYD N/A
  • GKOS N/A
  • Industry
  • BYD Hotels/Resorts
  • GKOS Medical/Dental Instruments
  • Sector
  • BYD Consumer Discretionary
  • GKOS Health Care
  • Exchange
  • BYD Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • BYD 6.6B
  • GKOS 5.4B
  • IPO Year
  • BYD 1993
  • GKOS 2015
  • Fundamental
  • Price
  • BYD $79.45
  • GKOS $87.22
  • Analyst Decision
  • BYD Buy
  • GKOS Strong Buy
  • Analyst Count
  • BYD 13
  • GKOS 13
  • Target Price
  • BYD $89.50
  • GKOS $122.08
  • AVG Volume (30 Days)
  • BYD 1.1M
  • GKOS 1.5M
  • Earning Date
  • BYD 10-23-2025
  • GKOS 10-29-2025
  • Dividend Yield
  • BYD 0.91%
  • GKOS N/A
  • EPS Growth
  • BYD 325.69
  • GKOS N/A
  • EPS
  • BYD 22.22
  • GKOS N/A
  • Revenue
  • BYD $4,070,839,000.00
  • GKOS $469,820,000.00
  • Revenue This Year
  • BYD N/A
  • GKOS $28.90
  • Revenue Next Year
  • BYD N/A
  • GKOS $25.48
  • P/E Ratio
  • BYD $3.58
  • GKOS N/A
  • Revenue Growth
  • BYD 5.91
  • GKOS 30.38
  • 52 Week Low
  • BYD $58.94
  • GKOS $73.16
  • 52 Week High
  • BYD $88.49
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • BYD 41.75
  • GKOS 57.53
  • Support Level
  • BYD $76.33
  • GKOS $73.16
  • Resistance Level
  • BYD $85.17
  • GKOS $102.80
  • Average True Range (ATR)
  • BYD 1.83
  • GKOS 5.51
  • MACD
  • BYD -0.44
  • GKOS 1.12
  • Stochastic Oscillator
  • BYD 35.29
  • GKOS 47.44

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: